Cardiol Therapeutics Inc. (CRDL) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cardiol Therapeutics Inc.

    NASDAQ: CRDL · Real-Time Price · USD
    1.07
    0.02 (1.90%)
    At close: Oct 03, 2025, 3:59 PM
    1.07
    0.00%
    Pre-market: Oct 06, 2025, 04:29 AM EDT

    Cardiol Therapeutics Ratios and Metrics

    Financials in CAD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.59 -2.56 -1.4 -3.19
    PEG Ratio
    		 -0.23 0.25 0.04 -0.55
    PS Ratio
    		 n/a n/a n/a 1.28K
    PB Ratio
    		 5.33 2.55 0.83 1.33
    P/FCF Ratio
    		 -5.25 -2.85K -1.58 -4.29
    P/OCF Ratio
    		 -5.26 -2.86K -1.59 -4.29
    OCF/S Ratio
    		 n/a n/a n/a -299.02
    Debt / Equity Ratio
    		 0.01 0.01 0.00 0.00
    Quick Ratio
    		 4.52 4.36 6.27 7.53
    Current Ratio
    		 4.52 4.36 6.27 7.53
    Asset Turnover
    		 n/a n/a n/a 0.00
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -1.48 -1 -0.59 -0.41
    Return on Assets
    		 -1.15 -0.77 -0.5 -0.36
    Return on Invested Capital
    		 -1.62 -1.05 -0.64 -0.47
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a 1.00
    Net Profit Margin
    		 n/a n/a n/a -401.7
    Pretax Profit Margin
    		 n/a n/a n/a -401.7
    Operating Profit Margin
    		 n/a n/a n/a -577.36
    FCF Margin
    		 n/a n/a n/a -299.18
    EBITDA Margin
    		 n/a n/a n/a -488.12

    Add to Watchlist